Nike Is Down 45% From Its Peak. The Brand Is Still There.
Monetary Elite The turnaround is real but slow. China is the problem nobody has solved yet.
Broadcom Is Down 27% From Its High. The AI Story Hasn’t Changed.
A selloff built on unmet expectations may be the most interesting entry point in the chip space right now.
Oil Just Fell Back to Pre-War Levels. The Real Trade Is Not Energy Stocks.
Crude is back near $68. The second-order beneficiaries of that collapse are hiding in plain sight.
GOOGL Reports July 22. The Stock Is Down About 10% From Its Post–Q1 Peak—and the Antitrust Risk Still Isn’t Cleanly Priced.
A ~$460B cloud backlog is real. So is a remedies decision that could reshape Google’s search and ad economics.
Big Pharma Has $1.3 Trillion to Spend. The Clock Is Running.
A patent cliff with a known deadline is forcing the largest acquisition wave in biopharma history.
SanDisk Is Down 15% This Week. BofA Just Raised Its Target to $2,500.
The AI memory shortage that drove a 700% gain is still intact. The pullback is the story.
SpaceX Is Now Public. The Real Question Starts Now.
SPCX went public at $135 and hit $225 in four days. Now it's back near $157. So what is this…
Broadcom Is Down 25% From Its High. The AI Numbers Say Something Different.
Custom chip revenue just grew 143% year over year. The selloff may be the opportunity.
Meta Is Trading at $621 and the July 29 Number Is the Only Thing That Matters
A 33% revenue beat, a $125B–$145B capex bill, and a stock still 22% off its all-time high.
Broadcom Is Down 25% From Its High. The Business Has Never Been Better.
Record AI revenue, a custom OpenAI chip, and a $1.8 trillion company trading at a discount.